Proteinuria	proteinuria	O	DISEASE	OTHERS	I
after	after	O	O	O	O
conversion	conversion	O	O	O	O
to	to	O	O	O	O
sirolimus	sirolimus	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
renal	renal	O	O	O	O
transplant	transplant	O	O	O	O
recipients	recipients	O	O	O	O
.	.	O	O	O	O

Sirolimus	sirolimus	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
SRL	srl	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
new	new	O	O	O	O
,	,	O	O	O	O
potent	potent	O	O	O	O
immunosuppressive	immunosuppressive	O	O	O	O
agent	agent	O	O	O	O
.	.	O	O	O	O

More	more	O	O	O	O
recently	recently	O	O	O	O
,	,	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
consequence	consequence	O	O	O	O
of	of	O	O	O	O
sirolimus	sirolimus	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
,	,	O	O	O	O
although	although	O	O	O	O
the	the	O	O	O	O
mechanism	mechanism	O	O	O	O
has	has	O	O	O	O
remained	remained	O	O	O	O
unclear	unclear	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
retrospectively	retrospectively	O	O	O	O
examined	examined	O	O	O	O
the	the	O	O	O	O
records	records	O	O	O	O
of	of	O	O	O	O
25	25	O	O	O	O
renal	renal	O	O	O	O
transplant	transplant	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
who	who	O	O	O	O
developed	developed	O	O	O	O
or	or	O	O	O	O
displayed	displayed	O	O	O	O
increased	increased	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
after	after	O	O	O	O
SRL	srl	CHEMICALS	O	OTHERS	I
conversion	conversion	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
cohort	cohort	O	O	O	O
(	(	O	O	O	O
14	14	O	O	O	O
men	men	O	O	O	O
,	,	O	O	O	O
11	11	O	O	O	O
women	women	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
SRL	srl	CHEMICALS	O	OTHERS	I
as	as	O	O	O	O
conversion	conversion	O	O	O	O
therapy	therapy	O	O	O	O
,	,	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
chronic	chronic	O	O	OTHERS	I
allograft	allograft	O	O	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
(	(	O	O	O	O
CAN	can	O	O	O	O
)	)	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
15	15	O	O	O	O
)	)	O	O	O	O
neoplasia	neoplasia	O	O	OTHERS	I
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
8)	8)	O	O	O	O
;	;	O	O	O	O
Kaposi	kaposi	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
sarcoma	sarcoma	O	DISEASE	OTHERS	I
,	,	O	O	O	O
Four	four	O	O	O	O
skin	skin	O	O	OTHERS	I
cancers	cancers	O	DISEASE	OTHERS	I
,	,	O	O	O	O
One	one	O	O	O	O
intestinal	intestinal	O	O	OTHERS	I
tumors	tumors	O	DISEASE	OTHERS	I
,	,	O	O	O	O
One	one	O	O	O	O
renal	renal	O	O	OTHERS	I
cell	cell	O	O	OTHERS	I
carsinom	carsinom	O	O	OTHERS	I
)	)	O	O	O	O
or	or	O	O	O	O
BK	bk	O	O	O	O
virus	virus	O	O	O	O
nephropathy	nephropathy	O	DISEASE	OTHERS	I
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
2	2	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

SRL	srl	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
started	started	O	O	O	O
at	at	O	O	O	O
a	a	O	O	O	O
mean	mean	O	O	O	O
of	of	O	O	O	O
78	78	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
42	42	O	O	O	O
(	(	O	O	O	O
15	15	O	O	O	O
to	to	O	O	O	O
163	163	O	O	O	O
)	)	O	O	O	O
months	months	O	O	O	O
after	after	O	O	O	O
transplantation	transplantation	O	O	O	O
.	.	O	O	O	O

Mean	mean	O	O	O	O
follow-up	follow-up	O	O	O	O
on	on	O	O	O	O
SRL	srl	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
was	was	O	O	O	O
20	20	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
12	12	O	O	O	O
(	(	O	O	O	O
6	6	O	O	O	O
to	to	O	O	O	O
43	43	O	O	O	O
)	)	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

Proteinuria	proteinuria	O	DISEASE	OTHERS	I
increased	increased	O	O	O	O
from	from	O	O	O	O
0.445	0.445	O	O	O	O
(	(	O	O	O	O
0	0	O	O	O	O
to	to	O	O	O	O
1.5	1.5	O	O	O	O
)	)	O	O	O	O
g/d	g/d	O	O	O	O
before	before	O	O	O	O
conversion	conversion	O	O	O	O
to	to	O	O	O	O
3.2	3.2	O	O	O	O
g/dL	g/dl	O	O	O	O
(	(	O	O	O	O
0.2	0.2	O	O	O	O
to	to	O	O	O	O
12	12	O	O	O	O
)	)	O	O	O	O
after	after	O	O	O	O
conversion	conversion	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
=	=	O	O	O	O
0.001	0.001	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Before	before	O	O	O	O
conversion	conversion	O	O	O	O
8	8	O	O	O	O
(	(	O	O	O	O
32	32	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
no	no	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
,	,	O	O	O	O
whereas	whereas	O	O	O	O
afterwards	afterwards	O	O	O	O
all	all	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
28	28	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
remained	remained	O	O	O	O
unchanged	unchanged	O	O	O	O
,	,	O	O	O	O
whereas	whereas	O	O	O	O
it	it	O	O	O	O
increased	increased	O	O	O	O
in	in	O	O	O	O
68	68	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
40	40	O	O	O	O
%	%	O	O	O	O
it	it	O	O	O	O
increased	increased	O	O	O	O
by	by	O	O	O	O
more	more	O	O	O	O
than	than	O	O	O	O
100	100	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

Twenty-eight	twenty-eight	O	O	O	O
percent	percent	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
showed	showed	O	O	O	O
increased	increased	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
to	to	O	O	O	O
the	the	O	O	O	O
nephrotic	nephrotic	O	DISEASE	OTHERS	I
range	range	O	O	O	O
.	.	O	O	O	O

Biopsies	biopsies	O	O	O	O
performed	performed	O	O	O	O
in	in	O	O	O	O
five	five	O	O	O	O
patients	patients	O	O	O	O
revealed	revealed	O	O	O	O
new	new	O	O	O	O
pathological	pathological	O	O	O	O
changes	changes	O	O	O	O
:	:	O	O	O	O
One	one	O	O	O	O
membranoproliferative	membranoproliferative	O	O	OTHERS	I
glomerulopathy	glomerulopathy	O	O	OTHERS	I
and	and	O	O	O	O
interstitial	interstitial	O	DISEASE	OTHERS	I
nephritis	nephritis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

These	these	O	O	O	O
patients	patients	O	O	O	O
showed	showed	O	O	O	O
persistently	persistently	O	O	O	O
good	good	O	O	O	O
graft	graft	O	O	O	O
function	function	O	O	O	O
.	.	O	O	O	O

Serum	serum	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
values	values	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
change	change	O	O	O	O
significantly	significantly	O	O	O	O
:	:	O	O	O	O
1.98	1.98	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O

0.8	0.8	O	O	O	O
mg/dL	mg/dl	O	O	O	O
before	before	O	O	O	O
SRL	srl	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
and	and	O	O	O	O
2.53	2.53	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
1.9	1.9	O	O	O	O
mg/dL	mg/dl	O	O	O	O
at	at	O	O	O	O
last	last	O	O	O	O
follow-up	follow-up	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
=	=	O	O	O	O
.14	.14	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Five	five	O	O	O	O
grafts	grafts	O	O	O	O
were	were	O	O	O	O
lost	lost	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
returned	returned	O	O	O	O
to	to	O	O	O	O
dialysis	dialysis	O	O	O	O
.	.	O	O	O	O

Five	five	O	O	O	O
patients	patients	O	O	O	O
displayed	displayed	O	O	O	O
CAN	can	O	O	O	O
and	and	O	O	O	O
Kaposi	kaposi	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
sarcoma	sarcoma	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Mean	mean	O	O	O	O
urinary	urinary	O	O	O	O
protein	protein	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
returned	returned	O	O	O	O
to	to	O	O	O	O
dialysis	dialysis	O	O	O	O
was	was	O	O	O	O
1.26	1.26	O	O	O	O
(	(	O	O	O	O
0.5	0.5	O	O	O	O
to	to	O	O	O	O
3.5	3.5	O	O	O	O
)	)	O	O	O	O
g/d	g/d	O	O	O	O
before	before	O	O	O	O
and	and	O	O	O	O
4.7	4.7	O	O	O	O
(	(	O	O	O	O
3	3	O	O	O	O
to	to	O	O	O	O
12	12	O	O	O	O
)	)	O	O	O	O
g/d	g/d	O	O	O	O
after	after	O	O	O	O
conversion	conversion	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
=	=	O	O	O	O
.01	.01	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Mean	mean	O	O	O	O
serum	serum	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
before	before	O	O	O	O
conversion	conversion	O	O	O	O
was	was	O	O	O	O
2.21	2.21	O	O	O	O
mg/dL	mg/dl	O	O	O	O
and	and	O	O	O	O
thereafter	thereafter	O	O	O	O
,	,	O	O	O	O
4.93	4.93	O	O	O	O
mg/dL	mg/dl	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
=	=	O	O	O	O
.02	.02	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Heavy	heavy	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
was	was	O	O	O	O
common	common	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
SRL	srl	CHEMICALS	O	OTHERS	I
as	as	O	O	O	O
rescue	rescue	O	O	O	O
therapy	therapy	O	O	O	O
for	for	O	O	O	O
renal	renal	O	O	O	O
transplantation	transplantation	O	O	O	O
.	.	O	O	O	O

Therefore	therefore	O	O	O	O
,	,	O	O	O	O
conversion	conversion	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
considered	considered	O	O	O	O
for	for	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
have	have	O	O	O	O
not	not	O	O	O	O
developed	developed	O	O	O	O
advanced	advanced	O	O	O	O
CAN	can	O	O	O	O
and	and	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
possibility	possibility	O	O	O	O
of	of	O	O	O	O
de	de	O	O	O	O
novo	novo	O	O	O	O
glomerular	glomerular	O	O	O	O
pathology	pathology	O	O	O	O
under	under	O	O	O	O
SRL	srl	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
requires	requires	O	O	O	O
further	further	O	O	O	O
investigation	investigation	O	O	O	O
by	by	O	O	O	O
renal	renal	O	O	O	O
biopsy	biopsy	O	O	O	O
.	.	O	O	O	O

